Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria

被引:0
|
作者
Kazeem B. Yusuff
Olubunmi Obe
Bonatson Y. Joseph
机构
[1] University of Ibadan,Department of Clinical Pharmacy & Pharmacy Administration, Faculty of Pharmacy
[2] University of Lagos,Department of Clinical Pharmacy & Biopharmacy, Faculty of Pharmacy
来源
Pharmacy World & Science | 2008年 / 30卷
关键词
Adherence; Anti-glycemic drugs; Blood glucose; Diabetes mellitus type 2; Nigeria; Prescribing; Self-management;
D O I
暂无
中图分类号
学科分类号
摘要
Objective To describe the pattern of anti-diabetic drug prescribing; ascertain the level of glycemic control, adherence with prescribed anti-diabetic medications, and diabetes self management practices among patients with type-2 diabetes in a tertiary care setting in Nigeria. Setting University College Hospital (UCH); a 900 bed teaching hospital with medical residents located in Ibadan, southwestern Nigeria. Method The study consisted of two phases. A cross-sectional review of randomly selected 200 case notes of type 2 diabetic patients that attended the Endocrinology clinic over 3 month; and crosssectional interviews, with a pre-tested Adherence and Self-Management Monitoring Tool (ASMMT), of 200 consecutive patients that presented their drug prescriptions at the satellite pharmacy unit over a 4 week period at a 900-bed teaching hospital located in Ibadan, South-Western Nigeria. Results Oral Hypoglycemic Agents (OHA) were prescribed for 86% (171) of cohorts while insulin and OHA was prescribed in 14% (29). About 70.8% (121) of patients on OHA were on combination therapy. The most frequently prescribed OHA combination was glibenclamide and metformin (95.8%). Glibenclamide was prescribed as twice daily regimen in 69% of cohorts. The most frequently documented side effect was hypoglycemia (60.3%). Only 44% (88) of cohorts had adequate glycemic control; of these, 93% (82) were adjudged adherent with prescribed anti-diabetic drugs. Interviews with the structured ASMMT revealed that 59% of patients were non-adherent with the previous anti-diabetic drugs due to lack of finance (51.7%); side effects (34.5%); perceived inefficacy of prescribed anti-diabetic drugs leading to self-medication with local herbs (13.8%). Only 20% of non-adherent patients claimed disclosure to physicians during consultation. The identified factors for non-disclosure were lack of privacy during consultation (58%); and short consultation time (42%). The knowledge and practice of critical components of diabetes self-management behaviours were generally low among the cohort studied. However, it was significantly higher among patient judged adherent with their prescribed anti-diabetic medications (P < 0.05). Conclusion Majority of patients with type 2 diabetes in an ambulatory tertiary care setting in Nigeria are managed with OHA combinations, mainly glibenclamide and metformin. While the current prescribing strategy achieved glycemic control in about one third of patients, majority are still not meeting the recommended blood glucose targets due to poor adherence with prescribed drug regimen, and poor knowledge and practice of successful self-management.
引用
收藏
页码:876 / 883
页数:7
相关论文
共 50 条
  • [31] Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin
    Szeremeta, Anna
    Jura-Poltorak, Agnieszka
    Grim, Alicja
    Kuznik-Trocha, Kornelia
    Olczyk, Pawel
    Ivanova, Diana
    Kiselova-Kaneva, Yoana
    Olczyk, Krystyna
    Komosinska-Vassev, Katarzyna
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [32] Efficacy and safety of repaglinide and metformin combination therapy compared to repaglinide monotherapy in Chinese oral anti-diabetic drug (OAD) naive type 2 diabetic patients
    Wang, W.
    Ning, G.
    Su, Q.
    Liu, J.
    Bu, R.
    DIABETOLOGIA, 2010, 53
  • [33] Unmet needs among patients with Type 2 diabetes and secondary failure to oral anti-diabetic agents
    Pitocco, D.
    Valle, D.
    Rossi, A.
    Gentilella, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (04) : 371 - 379
  • [34] Unmet needs among patients with Type 2 diabetes and secondary failure to oral anti-diabetic agents
    D. Pitocco
    D. Valle
    A. Rossi
    R. Gentilella
    Journal of Endocrinological Investigation, 2008, 31 : 371 - 379
  • [35] A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes-Components of Interventions
    Sapkota, Sujata
    Brien, Jo-anne E.
    Greenfield, Jerry R.
    Aslani, Parisa
    PLOS ONE, 2015, 10 (06):
  • [36] Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: A randomized, placebo-controlled clinical trial
    Sahib, Ahmed Salih
    JOURNAL OF INTERCULTURAL ETHNOPHARMACOLOGY, 2016, 5 (02): : 108 - 113
  • [37] Adherence to diabetic self-care practices and its associated factors among patients with type 2 diabetes in Addis Ababa, Ethiopia
    Bonger, Zeleke
    Shiferaw, Solomon
    Tariku, Eshetu Zerihun
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 963 - 970
  • [38] Anti-Diabetic and Insulinotropic Effects of p-Anisic Acid in High-Fat Diet and Streptozotocin Induced Type-2 Diabetic Rats
    Vora, Vishal
    Tirgar, Pravin
    Raval, Keval
    CHEMISTRY & BIODIVERSITY, 2024,
  • [39] The anti-diabetic PPARγ-activator rosiglitazone reduces MMP-9 serum levels in type-2 diabetic patients with coronary artery disease
    Marx, N
    Froehlich, J
    Siam, L
    Ittner, J
    Wierse, G
    Schmidt, A
    Hombach, V
    Koenig, W
    CIRCULATION, 2002, 106 (19) : 563 - 563
  • [40] Geographic differences in basal-supported oral therapy management in Chinese type 2 diabetic patients with inadequate glycemic control on oral anti-diabetic drugs
    Qiu, Liling
    Yao, Lin
    Xu, Wen
    Guo, Xiaohui
    Ji, Linong
    Li, Ming
    Weng, Jianping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 : 5 - 5